Your Questions, Answered

We’ve assembled the most frequently asked questions about Eversense into one place. Got a question that you can’t find the answer to? Contact us.

Filter by topic:

The Eversense® 365 Sensor is approximately 3.5 mm x 18.3 mm.

The Eversense® 365 Smart Transmitter Kit includes:

  • Smart Transmitter
  • Charging Accessories (Micro USB Cable and Wall Plug)
  • User Guide
  • Quick Reference Guide
  • Medical Device Card (for your wallet)
  • Next Steps Sheet

The Eversense® 365 CGM system consists of three main components: a glucose sensor, a Smart Transmitter, and a Mobile Medical Application (CGM Mobile App) to read the glucose data.

The Eversense® 365 Sensor Kit includes:

  • Pouch with the Sensor inside of a sensor holder

The following will cause the system to re-enter Initialization Phase.

  • Not completing a calibration within a 12-hour period during the Initialization Phase.
  • Not completing all 4 calibrations within 36 hours during the Initialization Phase.
  • Not completing required calibration entries during the Daily or Weekly Calibration Phase.
    • 1 calibration every 24 hours when the system is in 1 Daily Calibration Phase.
    • 1 calibration a week when the system is in 1 Weekly Calibration Phase.
  • When the last several blood glucose meter measurements are significantly different than the sensor glucose values.
  • If the smart transmitter is out of battery power for more than 16 hours.
  • When you receive a Sensor Check Alert.

The Eversense® 365 Sensor has a Warm-Up Phase, which is the period the sensor requires to adjust after the sensor has been inserted and before calibrations. The Warm-Up Phase lasts for 24 hours after the sensor is linked. Once the 24 hour period has passed, the Eversense® 365 App will prompt the user to perform a calibration.

Still have questions?

The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.

The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.

For important safety information, see bit.ly/eversensesafety

Eversense, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.


Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.

 

MKT-001692 Rev 1